5 completed, 2 unknown, 1 terminated, 1 withdrawn. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 5, Unknown 2, Terminated 1, Withdrawn 1 |
Follow Marfan Syndrome: new trials by email Literature Review of Marfan Syndrome trials Research Report on Marfan Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome Blood draw - Marfan Syndrome | Phase 3 | Withdrawn | Ann & Robert H Lurie Children's Hospital of Chicago | 2011-04-01 | 2016-02-05 | |
| Comparison of Aliskiren vs Negative Controls on Aortic Stiffness in Patients With MFS Aliskiren, Atenolol - Marfan Syndrome | Phase 3 | Completed | Samsung Medical Center | 30 | 2010-06-01 | 2017-06-05 |
| Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers Losartan, Placebo - Marfan Syndrome | Phase 3 | Completed | University Hospital, Ghent | 22 | 2009-11-01 | 2022-12-22 |
| Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome Losartan, Atenolol - Marfan Syndrome | Phase 3 | Unknown | Forteza, Albert, M.D. | 140 | 2008-10-01 | 2010-08-12 |
| Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome placebo, Losartan - Marfan Syndrome | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 303 | 2008-09-01 | 2015-11-04 |
| Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients Losartan and nebivolol, Losartan, Nebivolol - Marfan Syndrome | Phase 3 | Unknown | Fondazione IRCCS Policlinico San Matteo di Pavia | 291 | 2008-07-01 | 2011-07-22 |
| Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome Atenolol, Losartan - Marfan Syndrome | Phase 3 | Completed | Brigham and Women's Hospital | 40 | 2007-10-01 | 2014-09-09 |
| Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome Losartan Potassium, Atenolol - Marfan Syndrome | Phase 3 | Completed | Carelon Research | 608 | 2007-01-01 | 2025-03-07 |
| Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome Coversyl (perindopril) - Marfan Syndrome | Phase 3 | Completed | Bayside Health | 17 | 2004-01-01 | 2007-06-13 |
Aortic Aneurysm, Thoracic (1) · Camurati-Engelmann Syndrome (1) · Dissection, Ascending Aorta (1)
Abnormalities, Multiple (9) · Bone Diseases (9) · Bone Diseases, Developmental (9) · Cardiovascular Abnormalities (9) · Cardiovascular Diseases (9) · Congenital Abnormalities (9) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9) · Connective Tissue Diseases (9) · Genetic Diseases, Inborn (9) · Heart Defects, Congenital (9) · Heart Diseases (9) · Musculoskeletal Diseases (9) · Skin and Connective Tissue Diseases (9) · Aneurysm (2) · Aortic Diseases (2)
Losartan (6) · Atenolol (4) · Blood Specimen Collection (1) · Nebivolol (1) · Perindopril (1) · aliskiren (1)
Ann & Robert H Lurie Children's Hospital of Chicago (1) · Assistance Publique - Hôpitaux de Paris (1) · Bayside Health (1) · Brigham and Women's Hospital (1) · Carelon Research (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · Forteza, Albert, M.D. (1) · Samsung Medical Center (1) · University Hospital, Ghent (1)
United States (3) · Belgium (2) · Canada (1) · France (1) · Italy (1) · South Korea (1) · Spain (1)
Alberto Forteza, Dr (1) · Arturo Evangelista, Dr (1) · Bronwyn A Kingwell, PhD (1) · Duk-Kyung Kim, PhD MD (1) · Eloisa Arbustini, MD,FESC,FACC (1) · Julie De Backer, MD, PhD (1) · Luigi Tavazzi, MD,FESC,FACC (1) · Mark A Creager, MD (1) · Ron Lacro, MD (1)
PMID 17911499, PMID 16601194, PMID 17188619, PMID 19430350, PMID 20619242, PMID 23622922, PMID 25405392, PMID 25935877, PMID 26052700, PMID 29948025
U01HL068270 (1)